Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Antibiotic Adjuvant

Antibiotic Adjuvant?uq=kiHouaul
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE (Announced)
$95K LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of an AI based healthcare application designed to monitor and reduce antibiotic resistance. The company's application offers automated resistance control and features customized algorithm writer for individual facility needs, authoritative physician education and specializes at automatic protocols for de-escalation, duration of therapy and culture interpretation, enabling doctors to make quick and efficient decisions for patients.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 479 Jessie Street
  • San Francisco, CA 94103
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Antibiotic Adjuvant’s full profile, request a free trial.

Antibiotic Adjuvant Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 01-May-2018 $95K 00000 Announced Generating Revenue
2. Accelerator/Incubator 10-Jan-2018 00000 00000 00.00 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Antibiotic Adjuvant Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
IndieBio Accelerator/Incubator Minority 000 0000 000000 0
SOSV Venture Capital Minority 000 0000 000000 0
UF Innovate Accelerator/Incubator 000 0000 000000 0

Antibiotic Adjuvant Executive Team (4)

Name Title Board
Seat
Contact
Info
Guy La Torre Chief Executive Officer
Robert Yancey Jr. Co-Founder, President & Editor
David Flores Co-Founder

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »